Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Sentinel Cells for the Development of Molecular Tests to Control the Quality of Cryopreservation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01904825
Recruitment Status : Withdrawn
First Posted : July 22, 2013
Last Update Posted : July 22, 2013
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire Dijon

Brief Summary:

The aim is to set up tools that will serve as quality tracers for cryopreservation procedures.

To meet this objective, we have chosen to develop reference samples (sentinel cells) that, in the medium term, can be used as controls to guarantee the quality of preservation for biological samples.

The biological tools and an optimised follow-up strategy will make it possible to validate preservation procedures at the CRB in order to guarantee the perfect stability of samples and the validity of clinical studies.


Condition or disease
Aneurysm of the Abdominal Aorta

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 0 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 1 Day
Study Start Date : September 2006
Actual Primary Completion Date : August 2009
Actual Study Completion Date : August 2009



Primary Outcome Measures :
  1. Quality sentinel cells [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
Only patients of the CHU Dijon and Strasbourg
Criteria

Inclusion Criteria:

  • Age > or = 18 years
  • All patients presenting an abdominal aorta diameter of at least 5 cm at the time of discovery and who have surgery

Exclusion Criteria:

  • Patients who do not have aneurysm of the abdominal aorta
  • Refusal to sign the consent form for participation
  • Patients who do not wish to have their operation in Dijon or Strasbourg CHU

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01904825


Sponsors and Collaborators
Centre Hospitalier Universitaire Dijon
Investigators
Layout table for investigator information
Principal Investigator: Alain BONNIN CHU Dijon - Biological Resource Center
Additional Information:

Layout table for additonal information
Responsible Party: Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier: NCT01904825    
Other Study ID Numbers: Bonnin PHRC IR 2006
First Posted: July 22, 2013    Key Record Dates
Last Update Posted: July 22, 2013
Last Verified: July 2013
Additional relevant MeSH terms:
Layout table for MeSH terms
Aneurysm
Vascular Diseases
Cardiovascular Diseases